Petra Bohanec Grabar

Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism

Petra Bohanec Grabar, D Logar, B Lestan et al. · European Journal of Clinical Pharmacology · 2008 · 124 citations

Medicine, Genetics, Molecular Genetics +17

Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma

Barbara Faganel Kotnik, Iztok Grabnar, Petra Bohanec Grabar et al. · European Journal of Clinical Pharmacology · 2011 · 111 citations

Medicine, Genetics, Pharmacokinetics +17

Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients

Petra Bohanec Grabar, Blaž Rozman, Matija Tomšič et al. · European Journal of Clinical Pharmacology · 2008 · 91 citations

Medicine, Genetics, Pharmacology +9

Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis

Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman et al. · Drug Metabolism and Disposition · 2009 · 47 citations

Medicine, Pharmacokinetics, Pharmacology +17

Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis.

Petra Bohanec Grabar, D Logar, Matija Tomšič et al. · PubMed · 2009 · 38 citations

Medicine, Genetics, Molecular Genetics +17